CompoAtlas

UriDefense

Natural health product licensed in Canada

Licence holder
Knight Therapeutics Inc.
NPN or DIN-HM
80097434
Status
Active licence
Licence date
5 March 2020
Revision date
1 May 2026
Form
Capsule
Route of administration
Orale
Application type
Générale (non traditionelle)

If this product were sold in France

No point flagged by the rules we apply.

A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.

Composition

Medicinal composition not provided.

Non-medicinal ingredients

Amidon prégélatinisé, Cellulose en poudre, Dioxyde de titane, Jaune FD&C n° 6, Rouge FD&C N° 40, Stéarate de magnésium, Dioxyde de silicium, Hypromellose

PopulationAgeQuantity per servingFrequency
Adultesminimum: 19 years1 Capsuleminimum: 1 Tous les jours ; maximum: 2 Tous les jours

Uses authorised in Canada

UriDefense helps prevent and relieve symptoms of recurrent urinary tract infections (such as burning and urgency).

A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.

Warnings in Canada

Source

Official Health Canada record, licence 80097434

Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.

Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)

Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)

The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.

List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).

Has the product changed? Photograph the packaging.

Enter to analyse, Shift+Enter for a new line